Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

Addiction
C J A MorganH V Curran

Abstract

'Recreational' use of ketamine is spreading rapidly among young people. In healthy individuals an acute dose of the N-methyl D-aspartate (NMDA) receptor antagonist ketamine induces marked psychosis-like effects and cognitive impairments, but little is known about the long-term effects of the drug. To evaluate the long-term neuropsychiatric or cognitive consequences. A total of 150 individuals were assessed, 30 in each of five groups: frequent ketamine users, infrequent ketamine users, abstinent users, polydrug controls and non-users of illicit drugs. Twelve months later, 80% of these individuals were re-tested. Cognitive deficits were mainly observed only in frequent users. In this group, increasing ketamine use over the year was correlated with decreasing performance on spatial working memory and pattern recognition memory tasks. Assessments of psychological wellbeing showed greater dissociative symptoms in frequent users and a dose-response effect on delusional symptoms, with frequent users scoring higher than infrequent, abstinent users and non-users, respectively. Both frequent and abstinent using groups showed increased depression scores over the 12 months. These findings imply that heavy use of ketamine is harmful to aspe...Continue Reading

References

Jul 8, 1978·Lancet·P R Beck
Aug 29, 1990·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R G MorrisS P Butcher
Dec 1, 1986·The Journal of Nervous and Mental Disease·E M Bernstein, F W Putnam
Feb 1, 1993·The British Journal of Clinical Psychology·A BaddeleyI Nimmo-Smith
Jun 1, 1996·Brain : a Journal of Neurology·E L Wilding, M D Rugg
Mar 4, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D Jentsch, R H Roth
Nov 29, 2002·Psychopharmacology·Sargo AaltoJarmo Hietala
Jul 31, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rebekah A E HoneyP C Fletcher
Jul 31, 2004·Drug and Alcohol Dependence·Celia J A MorganH Valerie Curran
Aug 2, 2005·Schizophrenia Research·Oliver MasonGordon Claridge
Dec 7, 2005·The American Journal of Psychiatry·Rajesh NarendranAnissa Abi-Dargham
Mar 15, 2006·Trends in Cognitive Sciences·Paul C Fletcher, Garry D Honey
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
Sep 29, 2006·Psychopharmacology·Celia J A Morgan, H Valerie Curran
Nov 2, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maartje M L de WinWim van den Brink
Dec 19, 2006·European Addiction Research·Jim McCambridgeLuke Mitcheson
May 22, 2007·Neurotoxicity Research·Tomas PalomoRichard J Beninger
Jan 8, 2008·Psychological Medicine·C J A MorganH V Curran
Mar 22, 2008·Drug and Alcohol Dependence·L MuetzelfeldtH V Curran
Sep 9, 2008·British Journal of Nursing : BJN·Malcolm Watts

❮ Previous
Next ❯

Citations

Oct 26, 2012·Psychopharmacology·Lawrence P CarterMiriam Z Mintzer
Sep 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip R CorlettPaul C Fletcher
Aug 10, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R Edward RobertsCelia J A Morgan
Sep 19, 2012·Schizophrenia Bulletin·Daniel C Javitt
Apr 3, 2012·Harm Reduction Journal·Ariella A CameraLynn E Delisi
Feb 7, 2012·CNS Drugs·Sanjay J MathewJames W Murrough
Jan 18, 2014·L'Encéphale·P De MaricourtR Gaillard
Feb 26, 2013·Addictive Behaviors·Kahlen W S ChanChetwyn C H Chan
Aug 15, 2013·Life Sciences·Carlos VenâncioFrancisco Peixoto
Mar 23, 2012·Current Opinion in Supportive and Palliative Care·Rae F Bell
Oct 29, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Katharina E HoferAlessandro Ceschi
Jan 1, 2011·Emerging Health Threats Journal·Sarbjeet S KalsiPaul I Dargan
Feb 24, 2016·Neurotoxicology and Teratology·Bonnie L RobinsonJyotshna Kanungo
Feb 3, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Robert A SchoeversRudie Kortekaas
Dec 4, 2015·Medical Hypotheses·Ming-Chyi HuangShih-Ku Lin
Feb 22, 2012·Neuroscience and Biobehavioral Reviews·Jan G C van AmsterdamRaymond J M Niesink
Jun 21, 2011·The Journal of Urology·S K MakC Y Man
Feb 22, 2011·Bioorganic & Medicinal Chemistry Letters·Paola ZarantonelloFrancesco Cardullo
Dec 15, 2015·Journal of Clinical Psychopharmacology·Yena LeeRoger S McIntyre
Nov 18, 2015·Current Opinion in Psychiatry·Roger S McIntyre, Yena Lee
Nov 6, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Meiling ZhangLufeng Hu
Feb 15, 2011·BJU International·Dan WoodDavid Gillatt
Jul 23, 2011·Addiction·Celia J A MorganUNKNOWN Independent Scientific Committee on Drugs
Sep 24, 2014·Substance Abuse Treatment, Prevention, and Policy·Wen-Yin ChenShih-Ku Lin
Nov 3, 2010·Biological Psychiatry·Yanhui LiaoPaul C Fletcher
Jun 26, 2013·Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan·Waikwong TangGabor S Ungvari
Apr 8, 2016·The American Journal of Drug and Alcohol Abuse·Claudio Vidal GinéJosé López Guerrero

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.